Gut hormones could hold the key to fighting fatty liver disease
Promising therapeutic advancement, a new study reveals the crucial role of intestinal absorption in preventing dietary-induced fatty liver disease
2024-10-07
(Press-News.org)
The accumulation of fats in the liver is driven by high-fat diets and obesity, and is becoming an increasingly prevalent global health concern. Characterized by excessive fat accumulation in the liver, this condition poses significant risks for various metabolic disorders. While much of the existing research has focused on fat metabolism within the liver itself, emerging findings emphasize the critical role of the gut in this complex process. Proglucagon-derived peptides (PGDPs), including glucagon, GLP-1, and GLP-2, are known to be the key hormones that regulate lipid metabolism in the liver. Derived from the same precursor—proglucagon, previous studies have shown that both GLP-1 and GLP-2 are involved in lipid accumulation indirectly in the liver. However, their specific contributions to liver fat accumulation are not yet fully understood.
A new study, led by Associate Professor Yusuke Seino from Fujita Health University and published in Nutrients on 14 July, 2024, explores how PGDPs impact fat absorption and liver fat buildup. The team of researchers included lead researchers Mr. Koki Nishida, Mr. Atsushi Suzuki, and Mr. Yoshiki Hirooka from Fujita Health University, along with Mr. Yoshikata Hayashi from Nagoya University. Using genetically modified mice lacking PGDPs (GCGKO mice), the study investigates the response of mice to a high-fat diet (HFD) for seven days and sheds light on a potential new strategy for preventing fatty liver.
“When we subjected both GCGKO mice and control mice to an HFD for one week, the GCGKO mice exhibited a significantly lower increase in hepatic free fatty acid (FFA) and triglyceride levels, along with reduced adipose tissue weight,” highlighted Dr. Seino. These effects were attributed to a decrease in lipid absorption via the CD36 pathway in the intestinal tract, despite a reduced fat-burning capacity (β-oxidation) in the liver.
Additionally, the study found lower expression levels of genes involved in FFA oxidation in HFD-fed GCGKO mice. Particularly, Pparα (peroxisome proliferator receptor alpha) and Cd36 (cluster of differentiation 36) mRNA levels were reduced in the duodenum, correlating with a decrease in fat uptake in the intestines and increased fecal cholesterol content. This suggests that the absence of PGDPs prevents diet-induced fatty liver by lowering intestinal fat absorption.
Notably, the researchers found that despite lower fat-burning activity in the liver, the primary factor preventing fat accumulation was reduced fat absorption from the intestines. HFD-fed GCGKO mice also showed lower plasma triglyceride levels during the oral fat tolerance test (OFTT), further confirming reduced lipid absorption.
Moreover, the study underscores the intricate relationship between diet, hormonal responses, and intestinal microbiota. The HFD-fed GCGKO mice demonstrated notable shifts in gut bacteria, with an increase in Parabacteroides and a decrease in Lactobacillus, both linked to obesity resistance. These changes further point to the possibility of dietary and hormonal interventions to enhance gut health and metabolic function.
Adding further, Dr. Seino notes, “If we can examine in more detail how PGDPs specifically regulate lipid absorption in the gut, we hope to clarify the relationship between diet, hormones, and intestinal bacteria sufficiently to recommend a diet that is less conducive to obesity and fatty liver disease.”
Talking about the long-term implications of their research, Dr. Seino says, “In the future, oral dual antagonists of GLP-2 and glucagon could emerge as potential therapies for obesity and fatty liver, especially given their roles in insulin sensitivity and lipid metabolism.”
In summary, these findings pave the way for the development of targeted therapies aimed at combating this growing health problem, potentially improving outcomes for millions of people affected by fatty liver disease worldwide.
***
Reference
DOI: 10.3390/nu16142270
About Fujita Health University
Fujita Health University is a private university situated in Toyoake, Aichi, Japan. It was founded in 1964 and houses one of the largest teaching university hospitals in Japan in terms of the number of beds. With over 900 faculty members, the university is committed to providing various academic opportunities to students internationally. Fujita Health University has been ranked eighth among all universities and second among all private universities in Japan in the 2020 Times Higher Education (THE) World University Rankings. THE University Impact Rankings 2019 visualized university initiatives for sustainable development goals (SDGs). For the “good health and well-being” SDG, Fujita Health University was ranked second among all universities and number one among private universities in Japan. The university became the first Japanese university to host the "THE Asia Universities Summit" in June 2021. The university’s founding philosophy is “Our creativity for the people (DOKUSOU-ICHIRI),” which reflects the belief that, as with the university’s alumni and alumnae, current students also unlock their future by leveraging their creativity.
Website: https://www.fujita-hu.ac.jp/en/index.html
About Associate Professor Yusuke Seino from Fujita Health University
Dr. Yusuke Seino is an Associate Professor in the Departments of Endocrinology, Diabetes, and Metabolism at Fujita Health University School of Medicine in Toyoake, Japan. A respected researcher, he has authored over 68 publications, accumulating 410 citations in the field. He serves as the corresponding author for this paper. With a strong focus on advancing understanding in these critical areas, Dr. Seino is recognized for his significant contributions to endocrinology and metabolic research.
Funding information
This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to Y.S. (Yusuke Seino) (21K11608 and 24K14638) and Y.H. (Yoshitaka Hayashi) (23K24765), grants from the Japan Association for Diabetes Education and Care (to Y.S. (Yusuke Seino) and S.U. (Shinji Ueno)), and a research grant from Fujita Health University.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-10-07
The surge in the adoption of renewable energy, coupled with the rapid growth of the electric vehicle market in recent years has significantly increased the demand for high-performance, all-solid-state batteries. Compared to conventional liquid electrolyte-based batteries, solid-state batteries offer higher energy density, improved safety, longer lifespan, and reliable operation over a wide temperature range. However, there are still challenges to their widespread applications, including low ionic conductivity, high interfacial resistance, and the presence of particle-particle interfaces in the electrolyte, which leads to increased resistance and lower energy density.
Notably, ...
2024-10-07
The human microbiome plays a critical role in our health, influencing everything from disease development to treatment responses. This connection has captured the attention of scientists worldwide, eager to unlock its secrets. While traditional metagenomics has provided valuable insights, it falls short in resolving microbial diversity at the strain level and accurately profiling genes involved in antibiotic resistance. These limitations highlight the need for more advanced approaches.
To address this, a team of researchers led by Associate Professor Masahito Hosokawa, from Waseda University, in collaboration with bitBiome, Inc., developed a groundbreaking single-cell ...
2024-10-07
The winner of one of the UK’s biggest academic prizes has discovered what he believes is the key to long-term innovation and economic growth: unplanned intellectual friendships – like Greek philosophers Plato and Aristotle, or DNA pioneers James Watson and Francis Crick.
Professor Kirk Doran, an Associate Professor of Economics at the University of Notre Dame in Indiana in the United States, has been researching what drives innovation for 14 years – and has made his discovery by forensically analysing data including published research and census, tax, migration and historical data.
Professor Doran has ...
2024-10-07
Australians under 50 are experiencing stagnating life expectancy while older cohorts, especially men, are living longer, according to new research from The Australian National University (ANU).
The study examined longevity trends and patterns in six English-speaking countries (Australia, Canada, Ireland, New Zealand, the United Kingdom and the United States) and compared them with other high-income countries.
The results show striking similarities between English-speaking countries in terms of adverse health outcomes for young and middle-aged adults under fifty.
Lead author and ANU demographer, Dr Sergey Timonin, said the study ...
2024-10-07
Osaka, Japan – Plastics underpin much of modern life—areas like medicine, technology, and food safety would be unrecognizable without plastics and their useful properties. However, the toughness of plastics, which is often desirable, also makes them a dangerous pollutant and difficult to recycle. The solution to this serious and growing problem is making plastics easier to recycle.
In a study recently published in Chemical Science, researchers at Osaka University have found a way to make tough, high-performance polymers, the main component of plastics, that can be broken down easily and precisely into their component parts and ...
2024-10-07
Tobacco use remains a significant global health challenge, despite extensive control measures at both national and international levels. Smoking continues to be a leading cause of premature death, with exposure to tobacco—whether through active smoking or secondhand smoke—significantly increasing the risk of non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory conditions, and diabetes. These NCDs account for nearly 75% of annual global deaths.
A wide range of strategies has been developed to combat smoking and promote public health, including taxation, mass media campaigns, health warnings on packaging, marketing ...
2024-10-07
Targeting failure with new polymer technology to enhance sustainability
Sustainability is a complex problem with many different players and influenced by policies, society, and technical perspective.
We are reminded every day in the media of the unnecessary amount of waste that we are generating with pervasive pictures of plastic garbage patches floating in the oceans or stranded on our beaches.
Scientists within ASU’s School of Molecular Sciences (SMS) and the Biodesign Institute’s Center ...
2024-10-07
A new article published in Nature Reviews Disease Primers underscores the profound role that stigma can play in health care -- and how addressing stigma-related barriers can significantly improve health outcomes for individuals and communities around the world.
“Stigma has harmful effects on health, equity and justice,” says lead author Carmen Logie, a professor at the University of Toronto’s Factor-Inwentash Faculty of Social Work (FIFSW). "And while we need more rigorous evaluation of interventions ...
2024-10-07
The federal Patient Protection and Affordable Care Act (ACA) passed in 2010 includes a Dependent Coverage Expansion (DCE) provision that permits dependents to remain on their parents’ health insurance plans from age 19 to 25 years, the age group that has historically had the highest uninsured rate in the United States. A recent analysis reveals that during the ACA’s first decade, survival rates of DCE-eligible young adults with cancer have improved. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
To examine whether young adults with cancer diagnoses have ...
2024-10-07
A team of researchers from the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), the Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), and the Instituto de Ciencias de Materiales de Madrid (ICMM-CSIC) has made a significant breakthrough in understanding the underlying causes of cardiovascular disease in patients with Hutchinson-Gilford progeria syndrome (HGPS), an ultra-rare genetic disorder that accelerates the aging process. The most serious consequence of HGPS is the early onset of cardiovascular disease, leading to premature death at an average age of 14.5 years.
The study was led by Dr. Vicente Andrés, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Gut hormones could hold the key to fighting fatty liver disease
Promising therapeutic advancement, a new study reveals the crucial role of intestinal absorption in preventing dietary-induced fatty liver disease
